IBDEI0Q6 ; ; 01-FEB-2022
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,11762,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11762,1,3,0)
;;=3^Nephritic syndrome unspec w/ diffuse crescentic glomrlneph
;;^UTILITY(U,$J,358.3,11762,1,4,0)
;;=4^N05.7
;;^UTILITY(U,$J,358.3,11762,2)
;;=^5015548
;;^UTILITY(U,$J,358.3,11763,0)
;;=N05.8^^46^573^50
;;^UTILITY(U,$J,358.3,11763,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11763,1,3,0)
;;=3^Nephritic syndrome unspec w/ oth morphologic changes
;;^UTILITY(U,$J,358.3,11763,1,4,0)
;;=4^N05.8
;;^UTILITY(U,$J,358.3,11763,2)
;;=^5134085
;;^UTILITY(U,$J,358.3,11764,0)
;;=N05.9^^46^573^51
;;^UTILITY(U,$J,358.3,11764,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11764,1,3,0)
;;=3^Nephritic syndrome unspec w/ unspec morphologic changes
;;^UTILITY(U,$J,358.3,11764,1,4,0)
;;=4^N05.9
;;^UTILITY(U,$J,358.3,11764,2)
;;=^5134086
;;^UTILITY(U,$J,358.3,11765,0)
;;=N06.0^^46^573^39
;;^UTILITY(U,$J,358.3,11765,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11765,1,3,0)
;;=3^Isolated proteinuria w/ minor glomerular abnormality
;;^UTILITY(U,$J,358.3,11765,1,4,0)
;;=4^N06.0
;;^UTILITY(U,$J,358.3,11765,2)
;;=^5015549
;;^UTILITY(U,$J,358.3,11766,0)
;;=N06.1^^46^573^38
;;^UTILITY(U,$J,358.3,11766,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11766,1,3,0)
;;=3^Isolated proteinuria w/ focal & segmental glomerular lesions
;;^UTILITY(U,$J,358.3,11766,1,4,0)
;;=4^N06.1
;;^UTILITY(U,$J,358.3,11766,2)
;;=^5015550
;;^UTILITY(U,$J,358.3,11767,0)
;;=N06.2^^46^573^35
;;^UTILITY(U,$J,358.3,11767,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11767,1,3,0)
;;=3^Isolated proteinuria w/ diffuse membranous glomerulonephritis
;;^UTILITY(U,$J,358.3,11767,1,4,0)
;;=4^N06.2
;;^UTILITY(U,$J,358.3,11767,2)
;;=^5015551
;;^UTILITY(U,$J,358.3,11768,0)
;;=N06.3^^46^573^36
;;^UTILITY(U,$J,358.3,11768,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11768,1,3,0)
;;=3^Isolated proteinuria w/ diffuse mesangial prolif glomrlneph
;;^UTILITY(U,$J,358.3,11768,1,4,0)
;;=4^N06.3
;;^UTILITY(U,$J,358.3,11768,2)
;;=^5015552
;;^UTILITY(U,$J,358.3,11769,0)
;;=N06.4^^46^573^34
;;^UTILITY(U,$J,358.3,11769,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11769,1,3,0)
;;=3^Isolated proteinuria w/ diffuse endocaplry prolif glomrlneph
;;^UTILITY(U,$J,358.3,11769,1,4,0)
;;=4^N06.4
;;^UTILITY(U,$J,358.3,11769,2)
;;=^5015553
;;^UTILITY(U,$J,358.3,11770,0)
;;=N06.5^^46^573^37
;;^UTILITY(U,$J,358.3,11770,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11770,1,3,0)
;;=3^Isolated proteinuria w/ diffuse mesangiocapillary glomrlneph
;;^UTILITY(U,$J,358.3,11770,1,4,0)
;;=4^N06.5
;;^UTILITY(U,$J,358.3,11770,2)
;;=^5015554
;;^UTILITY(U,$J,358.3,11771,0)
;;=N06.6^^46^573^32
;;^UTILITY(U,$J,358.3,11771,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11771,1,3,0)
;;=3^Isolated proteinuria w/ dense deposit disease
;;^UTILITY(U,$J,358.3,11771,1,4,0)
;;=4^N06.6
;;^UTILITY(U,$J,358.3,11771,2)
;;=^5015555
;;^UTILITY(U,$J,358.3,11772,0)
;;=N06.7^^46^573^33
;;^UTILITY(U,$J,358.3,11772,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11772,1,3,0)
;;=3^Isolated proteinuria w/ diffuse crescentic glomerulonephritis
;;^UTILITY(U,$J,358.3,11772,1,4,0)
;;=4^N06.7
;;^UTILITY(U,$J,358.3,11772,2)
;;=^5015556
;;^UTILITY(U,$J,358.3,11773,0)
;;=N06.8^^46^573^40
;;^UTILITY(U,$J,358.3,11773,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11773,1,3,0)
;;=3^Isolated proteinuria w/ other morphologic lesion
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI0Q6 3787 printed Nov 22, 2024@17:03:48 Page 2
IBDEI0Q6 ; ; 01-FEB-2022
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,11762,1,0)
+2 ;;=^358.31IA^4^2
+3 ;;^UTILITY(U,$J,358.3,11762,1,3,0)
+4 ;;=3^Nephritic syndrome unspec w/ diffuse crescentic glomrlneph
+5 ;;^UTILITY(U,$J,358.3,11762,1,4,0)
+6 ;;=4^N05.7
+7 ;;^UTILITY(U,$J,358.3,11762,2)
+8 ;;=^5015548
+9 ;;^UTILITY(U,$J,358.3,11763,0)
+10 ;;=N05.8^^46^573^50
+11 ;;^UTILITY(U,$J,358.3,11763,1,0)
+12 ;;=^358.31IA^4^2
+13 ;;^UTILITY(U,$J,358.3,11763,1,3,0)
+14 ;;=3^Nephritic syndrome unspec w/ oth morphologic changes
+15 ;;^UTILITY(U,$J,358.3,11763,1,4,0)
+16 ;;=4^N05.8
+17 ;;^UTILITY(U,$J,358.3,11763,2)
+18 ;;=^5134085
+19 ;;^UTILITY(U,$J,358.3,11764,0)
+20 ;;=N05.9^^46^573^51
+21 ;;^UTILITY(U,$J,358.3,11764,1,0)
+22 ;;=^358.31IA^4^2
+23 ;;^UTILITY(U,$J,358.3,11764,1,3,0)
+24 ;;=3^Nephritic syndrome unspec w/ unspec morphologic changes
+25 ;;^UTILITY(U,$J,358.3,11764,1,4,0)
+26 ;;=4^N05.9
+27 ;;^UTILITY(U,$J,358.3,11764,2)
+28 ;;=^5134086
+29 ;;^UTILITY(U,$J,358.3,11765,0)
+30 ;;=N06.0^^46^573^39
+31 ;;^UTILITY(U,$J,358.3,11765,1,0)
+32 ;;=^358.31IA^4^2
+33 ;;^UTILITY(U,$J,358.3,11765,1,3,0)
+34 ;;=3^Isolated proteinuria w/ minor glomerular abnormality
+35 ;;^UTILITY(U,$J,358.3,11765,1,4,0)
+36 ;;=4^N06.0
+37 ;;^UTILITY(U,$J,358.3,11765,2)
+38 ;;=^5015549
+39 ;;^UTILITY(U,$J,358.3,11766,0)
+40 ;;=N06.1^^46^573^38
+41 ;;^UTILITY(U,$J,358.3,11766,1,0)
+42 ;;=^358.31IA^4^2
+43 ;;^UTILITY(U,$J,358.3,11766,1,3,0)
+44 ;;=3^Isolated proteinuria w/ focal & segmental glomerular lesions
+45 ;;^UTILITY(U,$J,358.3,11766,1,4,0)
+46 ;;=4^N06.1
+47 ;;^UTILITY(U,$J,358.3,11766,2)
+48 ;;=^5015550
+49 ;;^UTILITY(U,$J,358.3,11767,0)
+50 ;;=N06.2^^46^573^35
+51 ;;^UTILITY(U,$J,358.3,11767,1,0)
+52 ;;=^358.31IA^4^2
+53 ;;^UTILITY(U,$J,358.3,11767,1,3,0)
+54 ;;=3^Isolated proteinuria w/ diffuse membranous glomerulonephritis
+55 ;;^UTILITY(U,$J,358.3,11767,1,4,0)
+56 ;;=4^N06.2
+57 ;;^UTILITY(U,$J,358.3,11767,2)
+58 ;;=^5015551
+59 ;;^UTILITY(U,$J,358.3,11768,0)
+60 ;;=N06.3^^46^573^36
+61 ;;^UTILITY(U,$J,358.3,11768,1,0)
+62 ;;=^358.31IA^4^2
+63 ;;^UTILITY(U,$J,358.3,11768,1,3,0)
+64 ;;=3^Isolated proteinuria w/ diffuse mesangial prolif glomrlneph
+65 ;;^UTILITY(U,$J,358.3,11768,1,4,0)
+66 ;;=4^N06.3
+67 ;;^UTILITY(U,$J,358.3,11768,2)
+68 ;;=^5015552
+69 ;;^UTILITY(U,$J,358.3,11769,0)
+70 ;;=N06.4^^46^573^34
+71 ;;^UTILITY(U,$J,358.3,11769,1,0)
+72 ;;=^358.31IA^4^2
+73 ;;^UTILITY(U,$J,358.3,11769,1,3,0)
+74 ;;=3^Isolated proteinuria w/ diffuse endocaplry prolif glomrlneph
+75 ;;^UTILITY(U,$J,358.3,11769,1,4,0)
+76 ;;=4^N06.4
+77 ;;^UTILITY(U,$J,358.3,11769,2)
+78 ;;=^5015553
+79 ;;^UTILITY(U,$J,358.3,11770,0)
+80 ;;=N06.5^^46^573^37
+81 ;;^UTILITY(U,$J,358.3,11770,1,0)
+82 ;;=^358.31IA^4^2
+83 ;;^UTILITY(U,$J,358.3,11770,1,3,0)
+84 ;;=3^Isolated proteinuria w/ diffuse mesangiocapillary glomrlneph
+85 ;;^UTILITY(U,$J,358.3,11770,1,4,0)
+86 ;;=4^N06.5
+87 ;;^UTILITY(U,$J,358.3,11770,2)
+88 ;;=^5015554
+89 ;;^UTILITY(U,$J,358.3,11771,0)
+90 ;;=N06.6^^46^573^32
+91 ;;^UTILITY(U,$J,358.3,11771,1,0)
+92 ;;=^358.31IA^4^2
+93 ;;^UTILITY(U,$J,358.3,11771,1,3,0)
+94 ;;=3^Isolated proteinuria w/ dense deposit disease
+95 ;;^UTILITY(U,$J,358.3,11771,1,4,0)
+96 ;;=4^N06.6
+97 ;;^UTILITY(U,$J,358.3,11771,2)
+98 ;;=^5015555
+99 ;;^UTILITY(U,$J,358.3,11772,0)
+100 ;;=N06.7^^46^573^33
+101 ;;^UTILITY(U,$J,358.3,11772,1,0)
+102 ;;=^358.31IA^4^2
+103 ;;^UTILITY(U,$J,358.3,11772,1,3,0)
+104 ;;=3^Isolated proteinuria w/ diffuse crescentic glomerulonephritis
+105 ;;^UTILITY(U,$J,358.3,11772,1,4,0)
+106 ;;=4^N06.7
+107 ;;^UTILITY(U,$J,358.3,11772,2)
+108 ;;=^5015556
+109 ;;^UTILITY(U,$J,358.3,11773,0)
+110 ;;=N06.8^^46^573^40
+111 ;;^UTILITY(U,$J,358.3,11773,1,0)
+112 ;;=^358.31IA^4^2
+113 ;;^UTILITY(U,$J,358.3,11773,1,3,0)
+114 ;;=3^Isolated proteinuria w/ other morphologic lesion
